Log in or Sign up for Free to view tailored content for your specialty!
Dermatitis News
Paroxetine effective in refractory erythema of rosacea treatment
Paroxetine was effective and well tolerated among patients with refractory erythema of rosacea with 42.9% of patients experiencing clear or almost clear results, according to a study.
Speaker: Diet not likely cause of atopic dermatitis
MIAMI BEACH, Fla. — Decreasing the concern about food-induced atopic dermatitis will allow patients to focus on proper skin therapy and lower the risk of developing food allergies, according to a speaker at South Beach Symposium.
Log in or Sign up for Free to view tailored content for your specialty!
Ruxolitinib cream safe, effective for children with atopic dermatitis
Treatment with ruxolitinib cream was well tolerated and effective with no effect on blood counts or bone growth among children with atopic dermatitis, according to a study published in Annals of Allergy, Asthma & Immunology.
Adults taking dupilumab for atopic dermatitis also see improvements in mild asthma
Adults who were taking dupilumab for their atopic dermatitis also experienced significant improvements in their mild asthma, primarily in the first 16 weeks, according to a study published in Clinical and Translational Allergy.
New phase 3 data confirm prior positive findings of delgocitinib for chronic hand eczema
The DELTA 2 pivotal phase 3 clinical trial showed positive topline results for the use of delgocitinib cream in adults with moderate to severe chronic hand eczema, LEO Pharma announced in a press release.
FDA approves expanded use of Cibinqo for adolescents with atopic dermatitis
The FDA has approved a supplemental new drug application to expand the use of abrocitinib for adolescents with atopic dermatitis when other systemic drug products are not adequate or advisable, according to a press release.
Combination therapies often needed in rosacea treatment
MIAMI BEACH, Fla. — Rosacea is often a combination disease requiring combination therapies, according to a speaker here.
‘List doesn’t stop’ for JAK inhibitor potential in dermatology
MIAMI BEACH, Fla. — The past year has seen explosive development in Janus kinase inhibitors for dermatologic conditions, and it is possible they could continue to have indications throughout the specialty, according to a speaker here.
Social media negatively impacts mental health of adolescents with acne, atopic dermatitis
MIAMI BEACH, Fla. — Social media may contribute to the high rates of mental health problems and disorders among adolescents with acne and atopic dermatitis, according to a poster presented at South Beach Symposium.
Dupixent shows consistent, long-term efficacy in real-world studies
MIAMI BEACH, Florida — In two-real world studies, Dupixent treatment led to similar rapid and sustained improvements in patients with atopic dermatitis, according to a poster presentation at South Beach Symposium.
-
Headline News
Q&A: Oral injuries could be signs of abuse, neglect
September 04, 20245 min read -
Headline News
Providing menstrual products in schools ‘critical step’ to address period poverty
September 04, 20243 min read -
Headline News
Access to care, education may improve early introduction of allergens into infant diets
September 05, 20247 min read
-
Headline News
Q&A: Oral injuries could be signs of abuse, neglect
September 04, 20245 min read -
Headline News
Providing menstrual products in schools ‘critical step’ to address period poverty
September 04, 20243 min read -
Headline News
Access to care, education may improve early introduction of allergens into infant diets
September 05, 20247 min read